¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"autoimmune antineutrophil antibody"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
¿µ¹® autoimmune dieases ÇÑ±Û ÀÚ°¡¸é¿ªÁúȯ
¼³¸í   
  ¸é¿ªÀ̶õ ¿Ü°è¿¡¼­ µé¾î¿Â ¹°ÁúÀ» ÆÄ±«Çϰųª ¹«±â·ÂÈ­ ½ÃÄѼ­ ÀÚ½ÅÀ» º¸È£Çϴ ÀÏ·ÃÀÇ ÀÛ¿ëÀ» ¸»ÇÑ´Ù. ¸é¿ª¿¡¼­ °¡Àå Áß¿äÇÑ ´Ü°è´Â ÀڽŰú ¿ÜºÎ¿¡¼­ µé¾î¿Â ¹°ÁúÀ» ±¸ºÐÇϴ °ÍÀÌ´Ù. ÀÚ°¡ ¸é¿ªÁúȯÀ̶õ ÀÌ·± ÀڽŰú ¿ÜºÎ¿¡¼­ µé¾î¿Â ¹°ÁúÀÇ ±¸ºÐÀÌ È®½ÇÇÏÁö ¸øÇÏ¿© ÀÚ½ÅÀÇ ¹°Áú·Î À߸ø ÀνÄÇÏ¿© ½º½º·Î ÀÚ½ÅÀÇ ¹°ÁúÀ» ÆÄ±«Çϴ º´À» ¸»ÇÑ´Ù.
¿µ¹® antiglobulin antibody ÇÑ±Û Çױ۷κҸ°Ç×ü
¼³¸í   
  Ç×ü¿¡ ´ëÇÑ Ç×ü, Áï Æ¯Á¤ Ç×ü¿Í °áÇÕÇÒ ¼ö Àִ Ç×ü. ´ë°³ Àΰ£ÀÇ Ç×ü¸¦ Áã¿¡ ÁÖ»çÇÏ¿© Áã·Î ÇÏ¿©±Ý Àΰ£ Ç×ü¿¡ ´ëÇÑ Ç×ü¸¦ ¸¸µé°Ô ÇÑ´Ù(Áã¿¡ À־´Â Àΰ£ÀÇ Ç×üµµ ¿ÜºÎ¿¡¼­ µé¾î¿Â ¹°ÁúÀ̹ǷÎ). À̰ÍÀº ¿©·¯ °¡Áö ½ÇÇè¿¡¼­ Àΰ£ÀǠƯÁ¤Ç×ü¸¦ °ËÃâÇϴµ¥ ÀÌ¿ëÇÑ´Ù.
¿µ¹® antibody ÇÑ±Û Ç×ü
¼³¸í   
  »ç¶÷ÀÇ ¸ö¿¡¼­ ¸é¿ª¿¡ °ü°èÇϴ ¹°Áú. ¿ÜºÎ¿¡¼­ µé¾î¿Â ¹°Áú°ú ²À ¸Â°Ô °áÇÕÀ» ÇÏ¿©¼­ ±× ¹°ÁúÀÇ »ý¹°ÇÐÀû È°µ¿À» ¾ïÁ¦Çϰųª ÆÄ±«Çϰųª »ç¶÷ÀÇ ´Ù¸¥ ¸é¿ª¼¼Æ÷·Î ÇÏ¿©±Ý °ø°ÝÇϱ⠿ëÀÌÇÏ°Ô ÇØÁִ ±â´ÉÀ» °¡Áö°í ÀÖ´Ù. Ç×ü´Â ¸é¿ª±Û·ÎºÎ¸°À̶ó´Â °ÍÀ¸·Î ÀÌ·ç¾îÁ® ÀÖ°í ±× ÇüÅ¿¡ µû¶ó IgA, IgE, IgG, IgDµîÀ¸·Î ³ª´«´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antineutrophil cytoplasmic antibody
    Ç×Áß¼º±¸¼¼Æ÷ÁúÇ×ü
  • autoimmune antibody
    ÀÚ°¡¸é¿ªÇ×ü
  • autoimmune
    ÀÚ°¡¸é¿ª-
  • autoimmune disease
    ÀÚ°¡¸é¿ªÁúȯ
  • autoimmune disorder
    ÀÚ°¡¸é¿ªÁúȯ
  • autoimmune hemolytic anemia
    ÀÚ°¡¸é¿ª¿ëÇ÷ºóÇ÷
  • autoimmune hepatitis
    ÀÚ°¡¸é¿ª°£¿°
  • autoimmune inner ear disease
    ÀÚ°¡¸é¿ª¼Ó±Íº´, ÀÚ°¡¸é¿ª³»ÀÌÁúȯ
  • autoimmune progesterone dermatitis
    ÀÚ°¡¸é¿ªÇÁ·Î°Ô½ºÅ×·ÐÇǺο°
  • autoimmune reaction
    ÀÚ°¡¸é¿ª¹ÝÀÀ
  • autoimmune response
    ÀÚ°¡¸é¿ª¹ÝÀÀ
  • antibody
    Ç×ü
  • antibody absorption
    Ç×üÈí¼ö
  • antibody capture enzyme-linked immunosorbent assay
    Ç×üÆ÷ȹȿ¼Ò¸é¿ªÃøÁ¤(¹ý)
  • antibody diversity
    Ç×ü´Ù¾ç¼º
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antineutrophil cytoplasmic antibody
    Ç×Áß¼º±¸¼¼Æ÷ÁúÇ×ü
  • autoimmune antibody
    ÀÚ°¡¸é¿ªÇ×ü
  • autoimmune response
    ÀÚ°¡¸é¿ª¹ÝÀÀ
  • antibody
    Ç×ü
  • anti-double stranded deoxyribonucleic acid antib antibody
    Ç×ÀÌÁß°¡´Úµð¿£¿¡ÀÌÇ×ü
  • anti-dsDNA antibody
    (¢¡anti-double stranded deoxyribonucleic acid antibod) Ç×ÀÌÁß°¡´Úµð¿£¿¡ÀÌÇ×ü
  • anti-Ro antibody
    Ç׾˿ÀÇ×ü
  • anti-Sm antibody
    Ç׿¡½º¿¥Ç×ü
  • anticardiolipin antibody
    Ç×Ä«µð¿À¸®ÇÉÇ×ü
  • antinuclear antibody
    Ç×ÇÙÇ×ü
  • antiphospholipid antibody
    Ç×ÀÎÁöÁúÇ×ü
  • antisperm antibody
    Ç×Á¤ÀÚÇ×ü
  • atypical antibody
    ºñÁ¤ÇüÇ×ü
  • blocking antibody
    Â÷´ÜÇ×ü
  • polyclonal antibody
    ´ÙŬ·ÐÇ×ü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • autoimmune antibody
    ÀÚ°¡¸é¿ªÇ×ü
  • autoimmune
    ÀÚ°¡¸é¿ª-
  • autoimmune disease
    ÀÚ°¡¸é¿ªº´
  • autoimmune hepatitis
    (¢¡chronic active hepatitis) ¸¸¼ºÈ°µ¿°£¿°
  • autoimmune reaction
    ÀÚ°¡¸é¿ª¹ÝÀÀ
  • autoimmune response
    ÀÚ°¡¸é¿ª¹ÝÀÀ
  • autoimmune hemolytic anemia
    ÀÚ°¡¸é¿ª¿ëÇ÷ºóÇ÷
  • autoimmune inner ear disease
    ÀÚ°¡¸é¿ª¼Ó±Íº´
  • autoimmune progesterone dermatitis
    ÀÚ°¡¸é¿ªÇÁ·Î°Ô½ºÅ×·ÐÇǺο°
  • antibody
    Ç×ü
  • anaphylactic antibody
    ¾Æ³ªÇʶô½Ã½ºÇ×ü
  • anti-idiotype antibody
    Ç×À̵ð¿ÀŸÀÔÇ×ü, Ç×°³º°Æ¯ÀÌÇüÇ×ü
  • antibody diversity
    Ç×ü´Ù¾ç¼º
  • antibody excess
    Ç×ü°úÀ×
  • antibody half-life
    Ç×ü¹Ý°¨±â
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antineutrophil cytoplasmic autoantibody
    Ç×È£Áß±¸ ¼¼Æ÷Áú ÀÚ°¡Ç×ü
  • DF3 antibody
    DF3 Ç×ü
  • DL antobody => Donath-Landsteiner antibody
    DL Ç×ü
  • Donath-Landsteiner antibody
    µµ³ª¾²¶õÆ®½ºÅ¸ÀÌ³Ê Ç×ü
  • FTA (fluorescent treponemal antibody)
    ¸Åµ¶Çü±¤Ç×ü °Ë»ç¹ý
  • Fy antigen/antibody
    Fy Ç׿ø/Ç×ü
  • Gp 120/160 antibody
    Gp 120/160 Ç×ü
  • Gp 24 antibody
    Gp 24 Ç×ü
  • I antibody
    I Ç×ü
  • Jk antigen/antibody
    JkÇ׿ø/Ç×ü
  • Jo-1 antibody
    Jo-1 Ç×ü
  • Kell antigen and antibody
    ÄÌÇ׿øÇ×ü
  • Langmuir expression in drug-antibody binding
    ¾à¹°-Ç×ü °áÇÕ¿¡¼­ÀÇ ¶û¹¿¸£Ç¥Çö
  • Lewis antibody
    ·çÀ̽ºÇ×ü
  • Lutheran antibody
    ·çÅ×¶õÇ×ü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • autoimmune antineutrophil antibody
    ÀÚ±â¸é¿ª¼º Ç×È£Áß±¸Ç×ü(¡­ù÷û¿ñéϹù÷ô÷).
  • autoimmune antineutrophil antibody
    ÀÚ°¡¸é¿ª¼º Ç×È£Áß±¸Ç×ü(¡­ù÷û¿ñéϹù÷ô÷).
  • autoimmune antineutrophil antibody
    ÀÚ±â¸é¿ª¼º Ç×È£Áß±¸Ç×ü(?̴̡̰˴̧̰).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antineutrophil cytoplasmic autoantibody
    Ç×È£Áß±¸ ¼¼Æ÷Áú ÀÚ°¡Ç×ü
  • autoimmune antibody
    ÀÚ°¡¸é¿ªÇ×ü
  • warm-antibody autoimmune hemolytic anemia
    ¿Â³­Ç×üÀÚ°¡¸é¿ª¼º¿ëÇ÷¼ººóÇ÷
  • autoimmune
    ÀÚ°¡¸é¿ª(í»Ê«Øóæ¹).
  • autoimmune allergic encephalomyelitis
    ÀÚ°¡¸é¿ª ¾Ë·¹¸£±â¼º ³úô¼ö¿°
  • autoimmune complement fixation =AICF
    ÀÚ±â¸é¿ª¼º º¸Ã¼°áÇÕ¹ÝÀÀ(¡­ÜÍô÷Ì¿ùêÚãëë).
  • autoimmune complement fixation =AICF
    ÀÚ°¡¸é¿ª¼º º¸Ã¼°áÇÕ¹ÝÀÀ(¡­ÜÍô÷Ì¿ùêÚãëë).
  • autoimmune complement fixation =AICF
    ÀÚ±â¸é¿ª¼º º¸Ã¼°áÇÕ¹ÝÀÀ(?ËÓ̧˭̰ËÑËô).
  • autoimmune disease
    ÀÚ°¡ ¸é¿ª Áúȯ(í»Ê«Øóæ¹òðü´)
  • autoimmune disease
    ÀÚ°¡¸é¿ª¼ºÁúȯ(í»Ê«Øóæ¹àõòðü´)
  • autoimmune disease
    ÀÚ°¡¸é¿ªÁúȯ<º´>.
  • autoimmune disease
    ÀÚ°¡¸é¿ª¼ºÁúȯ
  • autoimmune disease,bypass of t-helper cell(low zone)
    T-º¸Á¶¼¼Æ÷ ³»¼º ¿ìȸ(¡­ÜÍð¾á¬øàÒ±àõéæüß)
  • autoimmune disease,immunologic tolerance
    ¸é¿ª°ü¿ë(Øóæ¹Î°é»)
  • autoimmune disease,sequestered antigen
    °Ý¸®Ç׿ø(̰×îù÷ê«)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • autoimmune complement fixation
    ÀÚ°¡¸é¿ª (í»Ê«Øóæ¹) º¸Ã¼°íÁ¤ (ÜÍô÷ͳïÒ)
  • autoimmune disease
    ÀÚ°¡¸é¿ªÁúȯ (í»Ê«Øóæ¹òðü´)
  • autoimmune response
    ÀÚ°¡¸é¿ª´ëÀÀ (í»Ê«Øóæ¹Óßëë)
  • acquired antibody
    "ȹµæÇ×ü (üòÔðù÷ô÷), ÈÄõ¼ºÇ×ü (ý­ô¸àõù÷ô÷)"
  • agglutinating antibody
    ÀÀÁýÇ×ü(ëêó¢ù÷ô÷)
  • anti-idiotype antibody
    Ç×(ù÷)À̵ð¿ÀŸÀÌÇÁ Ç×ü(ù÷ô÷)
  • anti-immunoglobulin antibody
    Ç׸鿪(ù÷Øóæ¹)±Û·ÎºÒ¸° Ç×ü(ù÷ô÷)
  • antibody
    Ç×ü(ù÷ô÷)
  • antibody binding fraction
    Ç×ü°áÇÕºÐȹ (ù÷ô÷Ì¿ùêÝÂüò)
  • antibody combining site
    Ç×ü°áÂø(ù÷ô÷Ì¿ó·)ÀÚ¸®
  • antibody dependent cellular cytotoxicity
    Ç×üÀÇÁ¸ÀÚ¸® ¼¼Æ÷¼º¼¼Æ÷µ¶¼º(ù÷ô÷ëîðíá¬øààõá¬øàÔ¸àõ)
  • antibody diversity
    Ç×ü ´Ù¾ç¼º(ù÷ô÷ÒýåÆàõ)
  • antibody fixation
    Ç×ü °íÁ¤(ù÷ô÷ͳïÒ)
  • antibody formation
    Ç×ü Çü¼º(ù÷ô÷û¡à÷)
  • antibody heterogeneity
    Ç×ü ºÒ±ÕÀϼº(ù÷ô÷ÝÕгìéàõ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • autoimmune
    ÀÚ°¡¸é¿ª
  • agglutination antibody titer
    ÀºÁýÇ×ü¿ª°¡
  • antibody
    Ç×ü
  • antigen antibody reaction
    Ç׿øÇ×ü¹ÝÀÀ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ANCA antineutrophil cytoplasm antibody
ACA abnormal coronary artery; acrodermatitis chronica atrophicans; acute cerebellar ataxia; adenocarcino...
AHA acetohydroxamic acid; acquired hemolytic anemia; acute hemolytic anemia; American Heart Association;...
AID acquired immunodeficiency disease; acute infectious disease; acute ionization detector; Agency for I...
EAT Eating Attitudes Test; Ehrlich ascites tumor; electro-aerosol therapy; epidermolysis acuta toxica; e...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MPO-ANCA Myeloperoxidase antineutrophil cytoplasmic antibody
ANCAs Antineutrophil cytoplasmic autoantibodies
AIH 1)autoimmune hepatitis
AHA autoimmune haemolytic anaemia
ALPS Autoimmune Lymphoproliferative Syndrome
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • antineutrophil cytoplasmic autoantibody
    Ç×È£Áß±¸ ¼¼Æ÷Áú ÀÚ°¡ Ç×ü
  • warm-antibody autoimmune hemolytic anemia
    ¿Â³­ Ç×ü ÀÚ°¡¸é¿ª¼º ¿ëÇ÷¼º ºóÇ÷
  • autoimmune
    ÀÚ°¡ ¸é¿ª
    ÀÚ°¡ ¸é¿ª¿¡ °üÇÑ.
  • autoimmune blood dyscrasia
    ÀÚ°¡ ¸é¿ª¼º Ç÷¾× ÀÌ»ó
  • autoimmune disorder
    ÀÚ°¡ ¸é¿ª Àå¾Ö
    ½Åü°¡ ÀÚ±â Àڽſ¡ ´ëÇØ Àå¾Ö°¡ ÀÖ´Â ¸é¿ª ¹ÝÀÀÀ» ÀÏÀ¸ÄÑ ·ù¸¶Æ¼¼º °üÀý¿°, ÇǺΠ°æÈ­Áõ°ú °°ÀÌ ÀÚ½ÅÀÇ Á¶Á÷ ÆÄ±«¸¦ À¯¹ßÇÏ´Â Áúȯ.
  • autoimmune hemolytic disease
    ÀÚ°¡ ¸é¿ª¼º ¿ëÇ÷¼º Áúȯ
  • autoimmune progesterone dermatitis
    ÀÚ°¡ ¸é¿ª ÇÁ·Î°Ô½ºÅ×·Ð ÇǺο°
  • autoimmune reaction
    ÀÚ°¡ ¸é¿ª ¹ÝÀÀ
  • autoimmune thyroiditis
    ÀÚ°¡ ¸é¿ª¼º °©»ó¼±¿°
  • polyendocrine autoimmune disease
    ´Ù³»ºÐºñ¼± ÀÚ°¡ ¸é¿ª Áúȯ
    µ¿ÀǾî=autoimmune
  • warm-reacting autoimmune hemolytic anemia
    »ó¿Â ¹ÝÀÀ¼º ÀÚ°¡ ¸é¿ª¼º ¿ëÇ÷¼º ºóÇ÷, ¿ÂÇ×ü¿¡ ÀÇÇÑ ¿ëÇ÷
    »ó¿Â ¹ÝÀÀ¼º Ç×ü
  • agglutination antibody titer
    ÀÀÁý Ç×ü ¿ª°¡
  • albumin agglutinating antibody
    ¾ËºÎ¹Î ÀÀÁý Ç×ü
  • alloimmune antibody
    µ¿Á¾ ¸é¿ª Ç×ü
  • anti-antibody
    Ç×Ç×ü
    Ç׿ø°ú °áÇÕÇÑ IgG classÀÇ Ç×ü ºÐÀڿ͸¸ °áÇÕÇÒ ¼ö ÀÖ´Â Ç×üÀÌ¸ç ºñƯÀÌÀûÀÎ ÀÀÁý IgG¿Í´Â ¹ÝÀÀÇÏÁö ¾Ê´Â Á¡¿¡¼­ ÀÌ Ç×ü´Â Ç׿ø Ç×ü °áÇÕ¹°ÀÇ °ËÃâ¿¡ ÀÀ¿ëµÇ°í ÀÖ´Ù. »ç¶÷ÀÇ ÀÚ¿¬ Ç×üÀÇ ÀÏÁ¾ÀÌ¸ç ·ù¸¶ÅäÀ̵å ÀÎÀÚÀÇ Æ¯¼öÇüÀ¸·Î º¸´Â °æÇâµµ ÀÖ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
antibodies, antineutrophil cytoplasmic Autoantibodies directed against cytoplasmic constituents of polymorphonuclear leukocytes and/or monocytes. They are used as specific markers for wegener's granulomatosis and other diseases, though their pathophysiological role is not clear. Anca are routinely detected by indirect immunofluorescence with three different patterns: c-anca (cytoplasmic), p-anca (perinuclear), and atypical anca.
(12 Dec 1998)
anaemia, haemolytic, autoimmune Acquired haemolytic anaemia due to the presence of autoantibodies which agglutinate or lyse the patient's own red cells.
(12 Dec 1998)
autoimmune <immunology> Pertaining to autoimmunity.
(02 Jan 1998)
autoimmune disease <disease> A disease process that involves the production of host antibodies to host tissue.
(27 Sep 1997)
autoimmune diseases Are illnesses which occur when the body tissues are attacked by its own immune system. The immune system is a complex organisation within the body that is designed normally to seek and destroy invaders of the body, particularly infections. Patients with these diseases have unusual antibodies in their blood that target their own body tissues.
(12 Dec 1998)
autoimmune haemolytic anaemia <haematology> A condition that results from the cellular destruction (haemolysis) of red blood cells due to antibodies formed to components on the surface of the red blood cells.
Origin: Gr. Haima = blood
(02 Jan 1998)
autoimmune hepatitis <pathology> A type of chronic active hepatitis that results from circulating auto-antibodies and chronic inflammation of the liver.
Symptoms are those of chronic active hepatitis.
(27 Sep 1997)
autoimmune thrombocytopenia purpura <haematology> A rare autoimmune disorder characterised by an acute shortage of platelets with resultant bruising and spontaneous bleeding.
The platelet count becomes exceedingly low and spontaneous bleeding from the gums, gastrointestinal tract and nose can be seen. Physical examination may demonstrate enlargement of the spleen. A typical rash occurs to do microscopic haemorrhage of small blood vessels in the skin.
Platelet counts under 10,000 can lead to spontaneous haemorrhage into the brain causing death. Treatment with corticosteroids is generally effective. Surgical removal of the spleen (splenectomy) is reserved for some patients.
Anti-platelet antibodies are detectable in some cases. It may present in either an acute or a chronic form.
Acronym: ITP
(20 Sep 2002)
autoimmune thyroiditis <endocrinology> Inflammation of the thyroid gland without the formation of pus. Noninfectious nonbacterial thyroid inflammation.
(27 Sep 1997)
polyendocrinopathies, autoimmune Autoimmune disease affecting multiple endocrine organs. Type I is characterised by childhood onset and mucocutaneous candidiasis, while type II exhibits any combination of adrenal insufficiency (addison's disease), lymphocytic thyroiditis, hypoparathyroidism, and gonadal failure. In both types organ-specific antibodies against a variety of endocrine glands have been detected. The type II syndrome differs from type I in that it is associated with HLA-a1 and b8 haplotypes, onset is usually in adulthood, and candidiasis is not present.
(12 Dec 1998)
hepatitis, autoimmune An unresolving, predominately periportal, hepatitis, usually with hypergammaglobulinaemia and serum autoantibodies. The existence of subgroups (types 1, 2, and 3) based on serological findings are controversial. Additionally, some patients have variant forms, where there are features associated with both autoimmune hepatitis and another type of chronic liver disease (overlap syndromes) or where there are findings incompatible with autoimmune hepatitis (outlier syndromes).
(12 Dec 1998)
systemic autoimmune diseases A group of connective tissue disease's characterised by the presence of autoantibodies responsible for immunopathologically mediated tissue lesions; systemic lupus erythematosus is the prototype.
(05 Mar 2000)
thyroiditis, autoimmune A progressive disease of the thyroid gland with antibodies in the blood stream directed against the thyroid and infiltration of the gland by lymphoctes (a key type of white blood cells involved in the immune response). This immune response is against one's own thyroid. (it is autoimmune.) predominantly affects women. Can be familial. Also called hashimoto's disease or hashimoto's thyroiditis.
(12 Dec 1998)
affinity antibody The measure of the interaction between molecules such as a receptor and its ligand. This interaction is reversible.
(05 Mar 2000)
agglutinating antibody 1. An antibody that causes clumping or agglutination of the bacteria or other cells which either stimulated the formation of the agglutinin, or contain immunologically similar, reactive antigen.
Synonym: agglutinating antibody, immune agglutinin.
2. A substance, other than a specific agglutinating antibody, that causes organic particles to agglutinate, commonly qualified, e.g., plant agglutinin.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • autoimmune
    ÀÚ±â(ÀÚ°¡)¸é¿ªÀÇ
  • antibody
    Ç×µ¶¼Ò; Ç×ü
  • antibody
    Ç×µ¶¼Ò;(Ç÷¾× ÁßÀÇ)Ç×ü
  • monoclonal antibody
    ´ÜÀÏ Å¬·Ð Ç×ü
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á